Prilenia and Ferrer to Present Pridopidine Data and PREVAiLS Updates at NEALS Meeting
The companies plan to share a post hoc analysis of a subgroup of ALS participants from the Phase 2 HEALEY Platform study at the NEALS Consortium 2026 Annual Meeting.